Skip to main content

Table 3 Meta-analysis of the association between LMR and clinicopathological features of ovarian cancer

From: Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis

Characteristics No. of studies No. of patients OR (95% CI) p Heterogeneity
I2 (%) Ph
Age (≥ 60 vs. <  60) 3 626 2.07 (1.22–3.50) 0.007 42 0.18
Gender (male vs. female) 4 4818 1.18 (0.68–2.04) 0.56 70 0.02
Smoking status (ever/current vs. never) 2 394 0.95 (0.63–1.45) 0.82 0 0.80
Differentiation (low vs. moderate/high) 5 4886 1.60 (1.10–2.32) 0.01 35 0.19
Tumor size (>  3 cm vs. <  3 cm) 2 496 1.86 (0.74–4.71) 0.19 71 0.06
T stage (III-IV vs. I-II) 3 4390 1.13 (1.01–1.28) 0.04 0 0.79
Lymph node metastasis (yes vs. no) 3 4390 1.22 (1.06–1.39) 0.005 0 0.67
Distant metastasis (yes vs. no) 1 124 1.46 (0.37–5.73) 0.59
Multiplicity (multiple vs. solitary) 2 496 1.04 (0.68–1.58) 0.86 0 0.49
Concomitant Cis (yes vs. no) 2 4322 0.88 (0.78–0.99) 0.03 0 0.87
  1. Cis carcinoma in situ